Gerlach K, Uhlig T, Hppe M, Khirt T, Saager L, Schmucker P
Department of Anaesthesiology, Schleswig-Holstein University Hospital, Campus Lbeck, Lübeck, Germany.
Minerva Anestesiol. 2003 Jun;69(6):563-9, 569-73.
The aim of this study was to assess postoperative analgesia after preincisional and postincisional administration of remifentanil.
Randomized trial, 24 hours.
University hospital, hospitalized care.
48 adult patients scheduled for lumbar vertebral surgery.
in group R5, patients received an infusion of 0.2 microg kg(-1) min(-1) remifentanil over 5 minutes, followed by a break of 15 minutes before anesthesia was started. Anesthesia was induced by infusion of 0.25 microg kg(-1) min(-1) remifentanil and a bolus of 1.5 microg kg(-1) propofol, followed by a continuous infusion of 2 to 3 microg kg(-1) h-1 propofol and 0.25 microg kg(-1) min(-1) remifentanil until end of anesthesia. In group R20, patients received 0.05 microg kg(-1) min(-1) remifentanil over 20 minutes before the induction of anesthesia. In group RL, anesthesia was induced and maintained with propofol. After surgery began, a remifentanil infusion of 0.5 microg kg(-1) min(-1) was given for 50 minutes, then reduced to 0.25 microg kg(-1) min(-1). The total remifentanil doses were similar in the 3 groups.
patients used patient-controlled analgesia (piritramide) for postoperative pain management. They recorded pain on a numeric rating scale every half hour.
Kruskal-Wallis test, pairwise Mann-Withney U-test, orthogonal polynomials (pain scores).
PATIENTS given postincisional remifentanil (RL) had the slowest decrease in postoperative pain scores (p<0.01) and the highest cumulative piritramide consumption (p<0.08).
The preincisional administration of remifentanil followed by a continuous infusion of 0.25 microg kg(-1) min(-1) appears to reduce pain scores and piritramid consumption when compared with a postincisional regimen.
本研究旨在评估切口前及切口后给予瑞芬太尼后的术后镇痛效果。
随机试验,为期24小时。
大学医院,住院护理。
48例计划行腰椎手术的成年患者。
在R5组中,患者在5分钟内接受0.2微克/千克(-1)分钟(-1)瑞芬太尼输注,然后在开始麻醉前休息15分钟。通过输注0.25微克/千克(-1)分钟(-1)瑞芬太尼和1.5微克/千克(-1)丙泊酚推注诱导麻醉,随后持续输注2至3微克/千克(-1)小时-1丙泊酚和0.25微克/千克(-1)分钟(-1)瑞芬太尼直至麻醉结束。在R20组中,患者在麻醉诱导前20分钟接受0.05微克/千克(-1)分钟(-1)瑞芬太尼输注。在RL组中,用丙泊酚诱导和维持麻醉。手术开始后,给予0.5微克/千克(-1)分钟(-1)瑞芬太尼输注50分钟,然后减至0.25微克/千克(-1)分钟(-1)。三组的瑞芬太尼总剂量相似。
患者使用患者自控镇痛(匹利卡明)进行术后疼痛管理。他们每半小时用数字评分量表记录疼痛程度。
Kruskal-Wallis检验、两两比较的Mann-Withney U检验、正交多项式(疼痛评分)。
切口后给予瑞芬太尼(RL组)的患者术后疼痛评分下降最慢(p<0.01),匹利卡明累积消耗量最高(p<0.08)。
与切口后给药方案相比,切口前给予瑞芬太尼并持续输注0.25微克/千克(-1)分钟(-1)似乎能降低疼痛评分和匹利卡明消耗量。